{"DataElement":{"publicId":"6438139","version":"1","preferredName":"Esophagus and Esophagogastric Junction Cancer AJCC Edition 8 Clinical Distant Metastasis M Category","preferredDefinition":"Extent of the distant metastasis for esophageal and esophagogastric junction carcinoma based on information obtained from the date of cancer diagnosis until the start of definitive treatment, or within four months (whichever is shorter), using AJCC Ed. 8 criteria.  This staging system applies to carcinomas including undifferentiated carcinoma, neuroendocrine cancers, adenosquamous carcinoma, and adenocarcinoma with neuroendocrine features.  Sarcomas, nonepithelial cancers, and gastrointestinal stromal tumors are not staged using this staging system.","longName":"ESOP_AJC8_CLN_M_CAT","context":"NCI Standards","contextVersion":"1","DataElementConcept":{"publicId":"2452344","version":"1","preferredName":"Esophageal Tumor Clinical M Stage","preferredDefinition":"information related to clinical evaluated M stage of or relating to the esophagus.","longName":"ESOPHAG_TUMOR_C_M_S","context":"NCI Standards","contextVersion":"1","ObjectClass":{"publicId":"2452342","version":"1","preferredName":"Esophageal Neoplasm","preferredDefinition":"Of or relating to the esophagus.:(NEE-o-PLAY-zha) Abnormal and uncontrolled cell growth.","longName":"C37950:C3262","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Esophageal","conceptCode":"C37950","definition":"Of or relating to the esophagus.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0D51E8D8-61C0-387C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-22","endDate":null,"createdBy":"ALAIS","dateCreated":"2006-02-22","modifiedBy":"ONEDATA","dateModified":"2006-02-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2207806","version":"1","preferredName":"Clinical M Stage","preferredDefinition":"Having to do with the examination and treatment of patients.:One criteria of the TMN staging system.  M refers to the presence of metastasis.","longName":"C25398:C25727","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical","conceptCode":"C25398","definition":"Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"M Category","conceptCode":"C25727","definition":"One criteria of the TNM staging system. M refers to the presence of metastasis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-30E1-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC:American Joint Committee on Cancer Cancer Staging Manual, 6th Ed., 2002","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"0D052842-7C86-4FD3-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-22","endDate":null,"createdBy":"ALAIS","dateCreated":"2006-02-22","modifiedBy":"TAYLORT","dateModified":"2018-10-04","changeDescription":"9/24/18 tt received permission for ownership transfer from CTEP to NCI Standards/BC.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6437951","version":"1","preferredName":"Esophagus and Esophagogastric Junction Carcinoma American Joint Committee on Cancer Edition 8 M Category","preferredDefinition":"A finding about one or more characteristics of esophagus and esophagogastric junction cancer, following the rules of the TNM AJCC v8 classification system. This staging system applies to carcinomas including squamous cell carcinoma, adenocarcinoma, adenosquamous carcinoma, undifferentiated carcinoma, neuroendocrine cancers, and adenocarcinoma with neuroendocrine features. Sarcomas, nonepithelial cancers, and gastrointestinal stromal tumors are not staged using this staging system. (from AJCC 8th Ed.)_One criteria of the TNM staging system. M refers to the presence of metastasis._A grouping of items based on some commonality or by user defined characteristics.","longName":"6437951v1.0","context":"NCI Standards","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"3","maxLength":"3","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"pM1","valueDescription":"Esophagus and Esophagogastric Junction Cancer pM1 TNM Finding v8","ValueMeaning":{"publicId":"6437953","version":"1","preferredName":"Esophagus and Esophagogastric Junction Cancer pM1 TNM Finding v8","longName":"6437953","preferredDefinition":"Esophagus and esophagogastric junction cancer with distant metastasis. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Esophagus and Esophagogastric Junction Cancer pM1 TNM Finding v8","conceptCode":"C133372","definition":"Esophagus and esophagogastric junction cancer with distant metastasis. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"76A058DE-C827-6CAD-E053-F662850A3BCB","latestVersionIndicator":"Yes","beginDate":"2018-09-24","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-09-24","modifiedBy":"ONEDATA","dateModified":"2018-09-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"76A058DE-C840-6CAD-E053-F662850A3BCB","beginDate":"2018-09-24","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-09-24","modifiedBy":"ONEDATA","dateModified":"2018-09-24","deletedIndicator":"No"},{"value":"cM1","valueDescription":"Esophagus and Esophagogastric Junction Cancer cM1 TNM Finding v8","ValueMeaning":{"publicId":"6437955","version":"1","preferredName":"Esophagus and Esophagogastric Junction Cancer cM1 TNM Finding v8","longName":"6437955","preferredDefinition":"Esophagus and esophagogastric junction cancer with distant metastasis. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Esophagus and Esophagogastric Junction Cancer cM1 TNM Finding v8","conceptCode":"C133368","definition":"Esophagus and esophagogastric junction cancer with distant metastasis. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"76A058DE-C84D-6CAD-E053-F662850A3BCB","latestVersionIndicator":"Yes","beginDate":"2018-09-24","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-09-24","modifiedBy":"ONEDATA","dateModified":"2018-09-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"76A058DE-C866-6CAD-E053-F662850A3BCB","beginDate":"2018-09-24","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-09-24","modifiedBy":"ONEDATA","dateModified":"2018-09-24","deletedIndicator":"No"},{"value":"cM0","valueDescription":"Esophagus and Esophagogastric Junction Cancer cM0 TNM Finding v8","ValueMeaning":{"publicId":"6437957","version":"1","preferredName":"Esophagus and Esophagogastric Junction Cancer cM0 TNM Finding v8","longName":"6437957","preferredDefinition":"Esophagus and esophagogastric junction cancer without evidence of distant metastasis. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Esophagus and Esophagogastric Junction Cancer cM0 TNM Finding v8","conceptCode":"C133367","definition":"Esophagus and esophagogastric junction cancer without evidence of distant metastasis. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"76A058DE-C873-6CAD-E053-F662850A3BCB","latestVersionIndicator":"Yes","beginDate":"2018-09-24","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-09-24","modifiedBy":"ONEDATA","dateModified":"2018-09-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"76A058DE-C88C-6CAD-E053-F662850A3BCB","beginDate":"2018-09-24","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-09-24","modifiedBy":"ONEDATA","dateModified":"2018-09-24","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"6437950","version":"1","preferredName":"Esophagus and Esophagogastric Junction Cancer TNM Finding v8 M Category Category","preferredDefinition":"A finding about one or more characteristics of esophagus and esophagogastric junction cancer, following the rules of the TNM AJCC v8 classification system. This staging system applies to carcinomas including squamous cell carcinoma, adenocarcinoma, adenosquamous carcinoma, undifferentiated carcinoma, neuroendocrine cancers, and adenocarcinoma with neuroendocrine features. Sarcomas, nonepithelial cancers, and gastrointestinal stromal tumors are not staged using this staging system. (from AJCC 8th Ed.):One criteria of the TNM staging system. M refers to the presence of metastasis.:A grouping of items based on some commonality or by user defined characteristics.","longName":"C133365:C25727:C25372","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Esophagus and Esophagogastric Junction Cancer TNM Finding v8","conceptCode":"C133365","definition":"A finding about one or more characteristics of esophagus and esophagogastric junction cancer, following the rules of the TNM AJCC v8 classification system. This staging system applies to carcinomas including squamous cell carcinoma, adenocarcinoma, adenosquamous carcinoma, undifferentiated carcinoma, neuroendocrine cancers, and adenocarcinoma with neuroendocrine features. Sarcomas, nonepithelial cancers, and gastrointestinal stromal tumors are not staged using this staging system. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"M Category","conceptCode":"C25727","definition":"One criteria of the TNM staging system. M refers to the presence of metastasis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Category","conceptCode":"C25372","definition":"A grouping of items based on some commonality or by user defined characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"76A058DE-C7FA-6CAD-E053-F662850A3BCB","latestVersionIndicator":"Yes","beginDate":"2018-09-24","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-09-24","modifiedBy":"ONEDATA","dateModified":"2018-09-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"76A058DE-C80B-6CAD-E053-F662850A3BCB","latestVersionIndicator":"Yes","beginDate":"2018-09-24","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-09-24","modifiedBy":"TAYLORT","dateModified":"2018-10-04","changeDescription":"10-4-18 Changed from Draft New to Released/tmt. Content reviewed and approved by requesting organization.  9-24-18 tt created for standardization.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"5574838","version":"1","longName":"Staging/Extent of Disease","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"6005920","version":"1","longName":"AJCC Edition 8","context":"NCI Standards"},{"publicId":"6437866","version":"1","longName":"Esophagus and Esophagogastric Junction","context":"NCI Standards"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Clinical M category","type":"Preferred Question Text","description":"Clinical M category","url":null,"context":"NCI Standards"}],"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"76A2D0F5-ADC9-5093-E053-F662850AADB1","latestVersionIndicator":"Yes","beginDate":"2018-09-24","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-09-24","modifiedBy":"TAYLORT","dateModified":"2018-10-04","changeDescription":"10-4-18 Changed from Draft New to Released/tmt. Content reviewed and approved by requesting organization.  9-24-18 tt created for standardization.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}